Aptalogic, Inc.

Ames, IA · Medtech · Private

Nucleic acid aptamer-based diagnostic platform for dengue and Zika virus differentiation

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Ames, IA
Total capital: $2.9M

Federal grants: $2.9M; 9 awards · 2015–2023; Rank in peer group#12 of 95
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 1 pending · first 2022; Rank in peer group#14 of 95

Capital timeline

Latest events

Aug 2023Federal grantHealth and Human S · Phase I · PA21259, SBIR, Phase I, Aptamer-upconverting nanocrystal conjugate lateral flow assay for immediate Ebola virus detection$264K
Aug 2019Federal grantHealth and Human S · Phase I · An aptasensor to distinguish Dengue virus from Zika virus$150K
Aug 2019Federal grantHealth and Human S · Phase I · An aptasensor to distinguish Dengue virus from Zika virus$150K
Aug 2017Federal grantHealth and Human S · Phase II · Early diagnosis of acute kidney injury by aptasensors$306K
Aug 2016Federal grantHealth and Human S · Phase II · Early diagnosis of acute kidney injury by aptasensors$374K
Aug 2016Federal grantHealth and Human S · Phase I · Detecting Ebola Virus Infections$330K
Sep 2015Federal grantHealth and Human S · Phase II · Early diagnosis of acute kidney injury by aptasensors$310K

Show 2 earlier federal awards

Apr 2015Federal grantHealth and Human S · Phase I · Detecting Ebola Virus Infections$683K
Feb 2015Federal grantHealth and Human S · Phase I · Detecting Ebola Virus Infections$352K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 95 peers

Line = median

Medtech · Instrument

Federal grants#12 · top 13%
Granted patents#14 · top 15%
Linked publications#1 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 2

Jan 25, 2022GrantedSelection and optimization of aptamers to recognize ebola markersUSPTOUS 11,231,420
PendingSelection And Optimization Of Aptamers To Recognize SgpUSPTOApplication 62654778

Recent research by its founders

Advances in Acute Ischemic Stroke 2025: Medical Treatments20260 cites
Efficacy and safety of early tirofiban administration after intravenous thrombolysis in patients with acute ischaemic stroke: the multicentre, randomised, double-blind, placebo-controlled RESCUE BT3 trial protocol20260 cites
Emergent Carotid Stenting for Acute Anterior Circulation Ischemic Stroke With Tandem Lesions: The Multicenter CERES-TANDEM Study.20260 cites

WINDMILL CARDIOVASCULAR SYSTEMS, INC.Similar federal contract value in Medtech · null in contracts
SONIX MEDICAL DEVICES INC.Similar federal contract value in Medtech · null in contracts
YAYA SCIENTIFIC LLCSimilar federal contract value in Medtech · null in contracts
SleepRes, Inc.Similar federal contract value in Medtech · null in contracts
Smart Human Dynamics, Inc.Similar federal contract value in Medtech · null in contracts
Theragnostic Technologies Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.